Patent · US Active

Motif of the beclin protein which interacts with anti-apoptotic members of the Bcl-2 protein family, and uses

US7919233B2 · kind B2 · utility

0Cited by
2References
5Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJan 31, 2006
Grant dateApr 5, 2011
Priority date
Expiry dateMar 7, 2027

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2510/00
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

The invention relates to a method of identifying modulators of programmed cell death, comprising an interaction between a motif of Beclin protein and an anti-apoptotic member of the family of Bcl-2 proteins and the detection of said interaction be means of fluorescence polarization. The modulators identified on the basis of said method are administered to cancer patients in order to induce apoptotic- and/or autophagic-type programmed cell death. The invention also relates to a motif of the Beclin protein which can interact with an anti-apoptic member of the family of Bcl-2 proteins and to the use thereof in order to induce programmed cell death in a cancer patient.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.